Protalix BioTherapeutics Inc (PLX)
1.75
-0.01
(-0.57%)
USD |
NYAM |
Dec 23, 16:00
1.75
0.00 (0.00%)
After-Hours: 20:00
Protalix BioTherapeutics Cash from Investing (Quarterly): 20.33M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Accuray Inc | -1.12M |
| AIM ImmunoTech Inc | 0.334M |
| Perspective Therapeutics Inc | -29.74M |
| Electromed Inc | -0.058M |
| Armata Pharmaceuticals Inc | -0.34M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 4.105M |
| Cash from Financing (Quarterly) | -20.42M |
| Free Cash Flow | 7.171M |
| Free Cash Flow Per Share (Quarterly) | 0.0495 |
| Free Cash Flow to Equity (Quarterly) | 24.44M |
| Free Cash Flow to Firm (Quarterly) | 4.143M |
| Free Cash Flow Yield | 5.22% |